MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (indian pharma)
- TORRENT PHARMA
TORRENT PHARMA Share Price (TORR)
Here is the latest stock price and chart of Torrent Pharma. For more details, see the Torrent Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
The Instant Income Summit: Free Registration
| Live BSE Quotes | Jul 7, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)2,335.05 | Open (Rs) 2,330.50 | High (Rs) 2,372.00 | Low (Rs) 2,306.90 |
| % Change-0.57 | Volume 19,697 | Value (Rs) 46,218,458 | 52-Week H/L 2,679.45 / 1,453.00 |
| Live NSE Quotes | Jul 7, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)2,333.15 | Open (Rs) 2,346.00 | High (Rs) 2,374.00 | Low (Rs) 2,304.40 |
| % Change-0.60 | Volume 588,076 | Value (Rs) 1,378,031,960 | 52-Week H/L 2,699.00 / 1,452.00 |
| Change | |||||
|---|---|---|---|---|---|
| 1 Day -0.57% | 1 Month -1.30% | 3 Months -1.11% | 1 Year 52.84% | 5 Years (CAGR)* 12.04% | 10 Years (CAGR)* 23.45% |
* Compound Annual Growth Rate
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 60.56 | P/E Ratio (x) 38.56 | Market Cap (Rs m) 395,230.56 | P/BV (x) 8.37 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
TORRENT PHARMA Share Price Today:
TORRENT PHARMA last traded price was down 0.6% to Rs 2,335.1 on the BSE. On the NSE, TORRENT PHARMA last traded price was down 0.6% to Rs 2,333.2. The total volume of shares traded was 0.6 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.2%. And the benchmark S&P BSE SENSEX was at 36,674.5 (up 0.5%).
Over the last 30 days, the TORRENT PHARMA share price is down 1.3%. And over the last one year, TORRENT PHARMA share price is up 52.8%.
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- BSE A Group Gainers Today
- NSE Above Rs 20 Gainers Today
- BSE Above Rs 20 Gainers Today
- BSE Sensex Gainers Today
- BSE Small Cap Gainers Today
- BSE 500 Gainers Today
- BSE A Group Losers Today
- Most Active Stocks Rs 1 to 2
- NSE Above Rs 20 Losers Today
- Buzzing Stocks Today
Today's Market
Indian Indices Continue Momentum; Sensex Ends 187 Points Higher(Closing)
Indian share markets end on a positive note with the Sensex up by 187 points, while the Nifty closed up by 36 points.
Related Views On News
TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)
Jan 28, 2020 | Updated on Jan 28, 2020For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.
TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)
Nov 1, 2019 | Updated on Nov 1, 2019For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.
More Views on NewsMost Popular
How to Find the Best Stocks for Day Trading - 1 (Fast Profits Daily)
Jul 2, 2020In the first of two videos, I'll show you how to identify the best stocks for intraday trading.
Be Prepared to Profit from the Coming Crash in Oil Prices (Fast Profits Daily)
Jun 25, 2020The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.
Two Agri Stocks Are Likely to Outperform Even in this Market (Profit Hunter)
Jul 2, 2020Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...
Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How... (Profit Hunter)
Jun 24, 2020Rahul is ready for a repeat of his famous 2008 Tata Motors call.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2020
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
TRACK TORRENT PHARMA
- Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON TORRENT PHARMA
TORRENT PHARMA - TEVA PHARMA COMPARISON
COMPARE TORRENT PHARMA WITH
FEATURED VIDEOS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.